A Systemic Inflammation Mortality Risk Assessment Contingency Table for Severe Sepsis*
- 1 February 2017
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 18 (2) , 143-150
Abstract
Objectives: We tested the hypothesis that a C-reactive protein and ferritin-based systemic inflammation contingency table can track mortality risk in pediatric severe sepsis. Design: Prospective cohort study. Setting: Tertiary PICU. Patients: Children with 100 separate admission episodes of severe sepsis were enrolled. Interventions: Blood samples were attained on day 2 of sepsis and bi-weekly for biomarker batch analysis. A 2 × 2 contingency table using C-reactive protein and ferritin thresholds was developed. Measurements and Main Results: A C-reactive protein of 4.08 mg/dL and a ferritin of 1,980 ng/mL were found to be optimal cutoffs for outcome prediction at first sampling (n = 100) using the Youden index. PICU mortality was increased in the “high-risk” C-reactive protein greater than or equal to 4.08 mg/dL and ferritin greater than or equal to 1,980 ng/mL category (6/13 [46.15%]) compared with the “intermediate-risk” C-reactive protein greater than or equal to 4.08 mg/dL and ferritin less than 1,980 ng/mL or C-reactive protein less than 4.08 mg/dL and ferritin greater than or equal to 1,980 ng/mL categories (2/43 [4.65%]), and the “low-risk” C-reactive protein less than 4.08 mg/dL and ferritin less than 1,980 ng/mL category (0/44 [0%]) (odds ratio, 36.43 [95% CI, 6.16–215.21]). The high-risk category was also associated with the development of immunoparalysis (odds ratio, 4.47 [95% CI, 1.34–14.96]) and macrophage activation syndrome (odds ratio, 24.20 [95% CI, 5.50–106.54]). Sixty-three children underwent sequential blood sampling; those who were initially in the low-risk category (n = 24) and those who subsequently migrated (n = 19) to the low-risk category all survived, whereas those who remained in the “at-risk” categories had increased mortality (7/20 [35%]; p < 0.05). Conclusions: A C-reactive protein- and ferritin-based contingency table effectively assessed mortality risk. Reduction in systemic inflammation below a combined threshold C-reactive protein of 4.08 mg/dL and ferritin of 1,980 ng/mL appeared to be a desired response in children with severe sepsis.Keywords
This publication has 31 references indexed in Scilit:
- An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New TasksNeonatology, 2012
- Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patientsPediatric Critical Care Medicine, 2011
- C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational studyCritical Care, 2011
- How to use: C-reactive protein: Table 1Archives of Disease in Childhood - Education & Practice Edition, 2010
- The Time Course of Blood C-reactive Protein Concentrations in Relation to the Response to Initial Antimicrobial Therapy in Patients with SepsisInfection, 2008
- Ferritin levels in children with severe sepsis and septic shockActa Paediatrica, 2007
- Patient and Hospital Correlates of Clinical Outcomes and Resource Utilization in Severe Pediatric SepsisPediatrics, 2007
- Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2004
- C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill PatientsaChest, 2003
- The Epidemiology of Severe Sepsis in Children in the United StatesAmerican Journal of Respiratory and Critical Care Medicine, 2003